Mangoceuticals, Inc.
MGRX
Rank in Stocks
#30765
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and... Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
Share Price
$0.197
Last synced: 2026-11-09
Market Cap
$4.38M
Change (1 day)
1.08%
Change (1 year)
-88.81%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Mangoceuticals, Inc. (MGRX)
Category
Healthcare
EPS for Mangoceuticals, Inc. (MGRX)
EPS as of June 2026 TTM: $-1.16
According to Mangoceuticals, Inc.'s latest financial reports, its current EPS (TTM) is $-1.16. At the end of 2025 the company had an EPS of $-2.17, an increase over its 2024 EPS of $-4.40.
EPS history for Mangoceuticals, Inc. from 2021 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.16 | -46.54% |
| 2025 | $-2.17 | -50.68% |
| 2024 | $-4.40 | -31.78% |
| 2023 | $-6.45 | 272.83% |
| 2022 | $-1.73 | 11,207.19% |
| 2021 | $-0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.86 | -432.76% |
US
|
|
| $1.64 | -241.38% |
US
|
|
| $-1.05 | -9.48% |
US
|
|
| $1.79 | -254.51% |
AU
|
|
| $2.08 | -279.31% |
US
|
Questions about Mangoceuticals, Inc.'s earnings per share (EPS)
What is Mangoceuticals, Inc.'s earnings per share (EPS)?
Mangoceuticals, Inc.'s earnings per share (EPS) over the last twelve months is $-1.16, as of Jun 2026.
What was Mangoceuticals, Inc.'s earnings per share (EPS) in 2025?
In 2025, Mangoceuticals, Inc.'s earnings per share (EPS) was $-2.17, compared with $-4.40 in 2024.
How has Mangoceuticals, Inc.'s earnings per share (EPS) changed since 2021?
From 2021 to 2025, Mangoceuticals, Inc.'s earnings per share (EPS) was highest in 2021 ($-0.02) and lowest in 2023 ($-6.45).
How does Mangoceuticals, Inc.'s earnings per share (EPS) compare with similar companies?
Mangoceuticals, Inc.'s earnings per share (EPS) ($-1.16) is lower than that of all 5 similar companies listed above. The highest among them is GE HealthCare Technologies Inc., with $3.86.